DuPont Defies Headwinds: Big Sale, Bigger Earnings, Soaring Stock

DuPont de Nemours (NYSE: DD | DD Price Prediction) released its fourth-quarter 2025 earnings on February 10, 2026, revealing a complex financial picture as the company navigates its latest structural transformation. Revenue for the quarter came in at $1.693 billion, falling 2.6% short of the $1.738 billion consensus estimate. Despite the top-line miss, the chemical giant demonstrated robust bottom-line resilience; adjusted EPS of $0.46 outperformed analyst expectations of $0.4445 by a healthy 3.5%.

The company reported a GAAP net loss of $108 million for the quarter. Management attributed this deficit largely to significant one-time items, including restructuring charges and debt extinguishment costs tied to the November 2025 spin-off of its Electronics business into the newly formed entity, Qnity.

Financial Highlights and Segment Performance

While the net loss grabbed headlines, DuPont’s underlying operational efficiency showed marked improvement. Operating EBITDA rose 4% year-over-year to $409 million, supported by a significant margin expansion of 80 basis points, bringing margins to 24.2%.

For the full-year 2025, DuPont’s performance remained steady:

• Revenue: $6.85 billion (2% organic growth)
• Operating EBITDA: $1.63 billion (up 6% YoY)
• Adjusted EPS: $1.68 (up 16% YoY)

Performance across the company’s core segments was a “tale of two cities,” reflecting broader macroeconomic shifts: Healthcare & Water Technologies generated $821 million with 3% organic growth driven by medical packaging and industrial water demand, while Diversified Industrials posted $872 million with a 4% organic decline due to construction market weakness.

CEO Lori Koch praised the company’s “strong, disciplined execution” during the earnings call, noting that DuPont successfully drove organic growth and double-digit adjusted EPS expansion despite lingering macro headwinds. The company issued 2026 guidance projecting revenue of $7.08 billion to $7.14 billion, operating EBITDA of $1.73 billion to $1.76 billion, and adjusted EPS of $2.25 to $2.30.

DuPont continues to aggressively reshape its portfolio and return value to shareholders. Following a $2 billion share buyback authorization initiated in November 2025, the company expects to further bolster its balance sheet by closing the $1.2 billion sale of its aramids business by the end of Q1 2026.

Investors appear rewarded by this lean-focused strategy; DuPont shares have surged 50.48% over the past 12 months, closing at $47.10 on February 9, 2026, just prior to the earnings release.